- Home
- DOCS vs BAX Comparison
DOCS vs BAX Comparison
Compare DOCS & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCS | BAX |
|---|---|---|
| Founded | 2010 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 10.2B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DOCS | BAX |
|---|---|---|
| Price | $24.23 | $17.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 9 |
| Target Price | ★ $51.85 | $22.13 |
| AVG Volume (30 Days) | 2.8M | ★ 9.5M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ 54.17 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | $570,399,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $15.07 | $1.90 |
| Revenue Next Year | $9.02 | $2.09 |
| P/E Ratio | $27.55 | ★ N/A |
| Revenue Growth | ★ 19.98 | 5.72 |
| 52 Week Low | $23.53 | $17.07 |
| 52 Week High | $76.51 | $35.03 |
Technical Indicators
Market Signals| Indicator | DOCS | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 30.26 | 34.77 |
| Support Level | $23.59 | N/A |
| Resistance Level | $27.09 | $19.31 |
| Average True Range (ATR) | 1.08 | 0.78 |
| MACD | 0.49 | -0.27 |
| Stochastic Oscillator | 19.80 | 7.13 |
Price Performance
Historical ComparisonAbout DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.